Learn how to combat the most complicated infectious conditions in small animals and become a sought-after professional in the veterinary sector”

There are many potentially infectious agents that threaten the health of pets day after day. The lack of prevention and hygiene from their owners degenerates, on numerous occasions, into high-risk situations not only for the affected animal, but also for the rest of the beings living around it. For example, it is difficult to ensure the food and health safety necessary to safeguard the welfare of a child living in the environment of a dog carrying an infectious disease. Additionally, climate change and the ability to move around the globe have led to the emergence of diseases in places where they did not exist before. Under these circumstances, the expert must master the latest advances in Infectious Diseases in Small Animals to respond to these challenges in an efficient way and ensure the health of humans and animals. 

For this reason, TECH has created this Hybrid Master's Degree, which seamlessly covers the entire breadth of the casuistry of this field of veterinary medicine, updating the diagnostic and therapeutic procedures of these pathologies based on the latest scientific evidence. Throughout the theoretical learning, the student will learn the new mechanisms of study and analysis of possible vectorial and bacterial diseases for the canine species, as well as the treatment of parasitic diseases in felines. Likewise, they will expand their skills in the approach to zoonoses, present in companion animals and potentially causing health problems in their owners. 

All this theoretical phase will be taught in a 100% online mode, which will allow students to manage their own study time to achieve effective learning, adapting their schedules to their own personal or professional needs. 

After successfully passing this didactic period, the student will have access to an on-site stay in a first level veterinary clinic where, surrounded by the best experts in infectious diseases, they will assimilate the tools that allow them to transfer to daily professional practice all the knowledge acquired in this program. 

The cure of Hybrid Master's Degree requires a comprehensive knowledge of their treatment. Acquire it with this Hybrid Master's Degree and become a successful professional”

This Hybrid Master's Degree in Infectious Diseases in Small Animals contains the most complete and up-to-date scientific program on the market.The most important features include: 

• Development of more than 100 clinical cases presented by veterinary professionals specialized in the treatment of infectious diseases in small animals
• The graphic, schematic, and practical contents with which they are created, provide scientific and practical information on the disciplines that are essential for professional practice
• Updated diagnostic methods for viral diseases in the canine patient 
• Innovative techniques for the treatment of vector-borneand bacterial diseases  
• Cutting-edge approaches to tropical pathologies in small animals 
• All of this will be complemented by theoretical lessons, questions to the expert, debate forums on controversial topics, and individual reflection assignments
• Content that is accessible from any fixed or portable device with an Internet connection
• Furthermore, you will be able to carry out a clinical internship in one of the best veterinary centers

Stand out in your career as a veterinarian expert in Infectious Diseases thanks to this Hybrid Master's Degree, taught with the most cutting-edge academic methods”

In this proposal for a Professional Master's Degree, of a professional nature and hybrid learning modality,the program is aimed at updating veterinary professionals who work with small animals with infectious diseases. The contents are based on the latest scientific evidence, and oriented in a didactic way to integrate theoretical knowledge in veterinary practice, and the theoretical-practical elements will facilitate the updating of knowledge and will allow decision making in the management of the animal.

Thanks to its multimedia content elaborated with the latest educational technology, they will allow the veterinary professional to obtain a situated and contextual learning, that is to say, a simulated environment that will provide an immersive learning programmed to train in real situations. This program is designed around Problem-Based Learning, whereby they must try to solve the different professional practice situations that arise during the course. This will be done with the help of an innovative system of interactive videos made by renowned experts.

This is a high-level academic program, revolutionary in the field of veterinary medicine, which will significantly enhance your growth in a booming professional market”

Seamlessly integrate your daily life with your studies thanks to the possibility of learning at your own pace"

The educational itinerary outlined by TECH for this Hybrid Master's Degree follows a logical and progressive order in the acquisition of knowledge. After an introduction to the different epidemiologies and diagnostic techniques related to the various bacterial and parasitic diseases, the student is soon immersed in the principles and generalities of the various clinical procedures. Once internalized, the planning foresees the learning of all infectious diseases and their respective treatments from an updated perspective.

You will have at your disposal a syllabus based on the latest developments in this sector and designed with the highest scientific rigor”

Module 1. Introduction and Laboratory Diagnosis

1.1. Prevalence and Epidemiology of Infectious Diseases in Small Animals

1.1.1. Introduction to the Epidemiology of Infectious Diseases
1.1.2. Epidemiological Characteristics of Infectious Diseases
1.1.3. Prevalence and Clinical Epidemiology

1.2. Diagnosis of Viral Diseases

1.2.1. The Role of Viruses in Veterinary Medicine
1.2.2. Viral Isolation
1.2.3. Antigen Detection Techniques by Immunological Techniques
1.2.4. Molecular Techniques (Polymerase Chain Reaction, PCR)

1.2.4.1. The Role of PCR Inhibitors

1.2.5. Histopathology
1.2.6. Serology Testing
1.2.7. Interpretation of Tests in Clinical Diagnosis

1.3. Diagnosis of Parasitic Diseases

1.3.1. The Role of Parasites in Veterinary Medicine
1.3.2. The Importance of the Coprological Analysis in the Daily Clinic

1.3.2.1. Coprological Techniques

1.3.3. Hematic Parasites, the Usefulness of Blood Smears
1.3.4. Serology in Parasitic Diseases

1.4. Diagnosis of Bacterial and Fungal Diseases

1.4.1. Direct Visualization Under the Microscope
1.4.2. Culture and Identification

1.4.2.1. Urine Culture and CFU
1.4.2.2. Anaerobic Bacteria
1.4.2.3. Interpretation of Antibiograms
1.4.2.4. Saprophyte, Opportunistic or Pathogenic

1.4.3. Molecular Techniques (Polymerase Chain Reaction, PCR)
1.4.4. Serology Testing
1.4.5. Histopathology

1.5. Procedures in Clinical Practice

1.5.1. Sampling for Bacterial Cultures
1.5.2. Sampling for Fungal Cultures
1.5.3. Blood Cultures
1.5.4. Anaerobic Cultures
1.5.5. Conservation of Microbiology Samples
1.5.6. Serum or Plasma? Hysop With or Without Medium?

1.6. Cytology Applied to Diagnosis. Skin

1.6.1. General Aspects
1.6.2. Techniques for Obtaining Samples
1.6.3. Staining Techniques
1.6.4. Principles of Cytological Interpretation

1.6.4.1. Interpretation of Cell Lines
1.6.4.2. Bacterial Diseases
1.6.4.3. Fungal Diseases
1.6.4.4. Parasitic Diseases

1.7. Cytology Applied to Diagnosis. Lymph Nodes

1.7.1. General Aspects
1.7.2. Techniques for Obtaining Samples
1.7.3. Staining Techniques
1.7.4. Principles of Cytological Interpretation

1.7.4.1. Interpretation of Cell Lines
1.7.4.2. Bacterial Diseases
1.7.4.3. Fungal Diseases
1.7.4.4. Parasitic Diseases

1.8. Cytology Applied to Diagnosis. Blood and Bone Marrow

1.8.1. General Aspects
1.8.2. Techniques for Obtaining Samples
1.8.3. Staining Techniques
1.8.4. Principles of Cytological Interpretation

1.8.4.1. Interpretation of Cell Lines
1.8.4.2. Bacterial Diseases
1.8.4.3. Fungal Diseases
1.8.4.4. Parasitic Diseases
1.8.4.5. Viral Diseases

1.9. Cytology Applied to Diagnosis. Respiratory and Digestive System

1.9.1. General Aspects
1.9.2. Techniques for Obtaining Samples
1.9.3. Staining Techniques
1.9.4. Principles of Cytological Interpretation

1.9.4.1. Interpretation of Cell Lines
1.9.4.2. Bacterial Diseases
1.9.4.3. Fungal Diseases
1.9.4.4. Parasitic Diseases

1.10. Cytology Applied to Diagnosis. Sensory Organs

1.10.1. General Aspects
1.10.2. Techniques for Obtaining Samples
1.10.3. Staining Techniques
1.10.4. Principles of Cytological Interpretation

1.10.4.1. Interpretation of Cell Lines
1.10.4.2. Bacterial Diseases
1.10.4.3. Fungal Diseases
1.10.4.4. Parasitic Diseases

Module 2. Infectious Diseases in the Canine Species (I). Viral Diseases

2.1. Distemper

2.1.1. Etiological Agent
2.1.2. Epidemiology
2.1.3. Clinical Manifestations
2.1.4. Specific Diagnosis
2.1.5. Treatment

2.2. Parvovirus and Enteric Viruses

2.2.1. Etiological Agents Involved
2.2.2. Epidemiology
2.2.3. Pathogenesis
2.2.4. Clinical Manifestations and Lesions
2.2.5. Specific Diagnosis
2.2.6. Treatment

2.3. Canine Herpesvirus

2.3.1. Etiological Agent
2.3.2. Epidemiology
2.3.3. Pathogenesis
2.3.4. Clinical Manifestations and Lesions
2.3.5. Specific Diagnosis
2.3.6. Treatment

2.4. Kennel Cough

2.4.1. Etiological Agents Involved
2.4.2. Epidemiology
2.4.3. Pathogenesis
2.4.4. Clinical Manifestations and Lesions
2.4.5. Specific Diagnosis
2.4.6. Treatment

2.5. Canine Influenza and other Respiratory Viruses

2.5.1. Etiological Agents Involved
2.5.2. Epidemiology
2.5.3. Pathogenesis
2.5.4. Clinical Manifestations and Lesions
2.5.5. Specific Diagnosis
2.5.6. Treatment

2.6. Canine Infectious Hepatitis

2.6.1. Etiological Agent
2.6.2. Epidemiology
2.6.3. Pathogenesis
2.6.4. Clinical Manifestations and Lesions
2.6.5. Specific Diagnosis
2.6.6. Treatment

2.7. Viral Papillomatosis

2.7.1. Etiological Agent
2.7.2. Epidemiology
2.7.3. Pathogenesis
2.7.4. Clinical Manifestations and Lesions
2.7.5. Specific Diagnosis
2.7.6. Treatment

2.8. Rabies and Pseudorabies (Aujeszky's Disease)

2.8.1. Etiological Agents
2.8.2. Clinical Manifestations
2.8.3. Specific Diagnosis
2.8.4. Problem Situations
2.8.5. Preventive Strategies

2.9. Botulism

2.9.1. Etiological Agents
2.9.2. Epidemiology
2.9.3. Clinical Manifestations
2.9.4. Specific Diagnosis
2.9.5. Treatment

2.10. Tetanus

2.10.1. Etiological Agent
2.10.2. Epidemiology
2.10.3. Clinical Manifestations
2.10.4. Specific Diagnosis
2.10.5. Treatment

Module 3. Infectious Diseases in the Canine Species (II). Vector and Bacterial Diseases (I)

3.1. Ehrlichiosis

3.1.1. Epidemiology
3.1.2. Clinical Manifestations
3.1.3. Specific Diagnosis
3.1.4. Treatment

3.2. Piroplasmosis or Babesia

3.2.1. Etiology and Pathogenesis
3.2.2. Host and Transmission
3.2.3. Clinical Signs
3.2.4. Diagnosis and Treatment

3.3. Anaplasmosis

3.3.1. Etiological Agents
3.3.2. Epidemiology
3.3.3. Clinical Manifestations
3.3.4. Specific Diagnosis
3.3.5. Treatment

3.4. Hemotropic Mycoplasma

3.4.1. Etiological Agents
3.4.2. Epidemiology
3.4.3. Clinical Manifestations
3.4.4. Specific Diagnosis
3.4.5. Treatment

3.5. Hepatozoonosis

3.5.1. Etiological Agents
3.5.2. Epidemiology
3.5.3. Clinical Manifestations
3.5.4. Specific Diagnosis
3.5.5. Treatment

3.6. Visceral Leishmaniasis

3.6.1. Etiology and Pathogenesis
3.6.2. Host and Transmission
3.6.3. Clinical Signs
3.6.4. Diagnosis and Treatment

3.7. Neospora and Toxoplasma

3.7.1. Etiological Agents
3.7.2. Epidemiology
3.7.3. Clinical Manifestations
3.7.4. Specific Diagnosis
3.7.5. Treatment

3.8. Brucellosis

3.8.1. Etiological Agents
3.8.2. Epidemiology
3.8.3. Clinical Manifestations
3.8.4. Specific Diagnosis
3.8.5. Treatment

3.9. Dirofilariasis

3.9.1. Etiological Agents
3.9.2. Epidemiology
3.9.3. Clinical Manifestations
3.9.4. Specific Diagnosis
3.9.5. Treatment

3.10. Bartonellosis and borreliosis

3.10.1. Etiological Agents
3.10.2. Epidemiology
3.10.3. Clinical Manifestations
3.10.4. Specific Diagnosis
3.10.5. Treatment

Module 4. Infectious Diseases in the Canine Species (III). Bacterial (II), Parasitic and Fungal Diseases

4.1. Leptospirosis

4.1.1. Etiological Agents
4.1.2. Epidemiology
4.1.3. Clinical Manifestations
4.1.4. Specific Diagnosis
4.1.5. Treatment

4.2. Mycobacteriosis

4.2.1. Etiological Agents
4.2.2. Epidemiology
4.2.3. Clinical Manifestations
4.2.4. Specific Diagnosis
4.2.5. Treatment

4.3. Superficial Mycoses

4.3.1. Dermatophytosis

4.3.1.1. Etiological Agents
4.3.1.2. Epidemiology
4.3.1.3. Clinical Manifestations
4.3.1.4. Specific Diagnosis
4.3.1.5. Treatment

4.3.2. Malassezia Dermatitis

4.3.2.1. Etiological Agent
4.3.2.2. Epidemiology
4.3.2.3. Clinical Manifestations
4.3.2.4. Specific Diagnosis
4.3.2.5. Treatment

4.4. Deep Mycosis

4.4.1. Etiological Agents
4.4.2. Epidemiology
4.4.3. Clinical Manifestations
4.4.4. Specific Diagnosis
4.4.5. Treatment

4.5. Aspergillosis

4.5.1. Etiological Agents
4.5.2. Epidemiology
4.5.3. Clinical Manifestations
4.5.4. Specific Diagnosis
4.5.5. Treatment

4.6. Enterobacteriaceae

4.6.1. Etiological Agents
4.6.2. Epidemiology
4.6.3. Clinical Manifestations
4.6.4. Specific Diagnosis
4.6.5. Treatment

4.7. Pulmonary Parasitosis

4.7.1. Etiological Agents
4.7.2. Epidemiology
4.7.3. Clinical Manifestations
4.7.4. Specific Diagnosis
4.7.5. Treatment

4.8. Gastrointestinal Parasitosis I. Protozoa

4.8.1. Epidemiology
4.8.2. Clinical Manifestations
4.8.3. Specific Diagnosis
4.8.4. Treatment

4.9. Gastrointestinal Parasitosis II. Helminths

4.9.1. Epidemiology
4.9.2. Clinical Manifestations
4.9.3. Specific Diagnosis
4.9.4. Treatment

4.10. Protothecosis and Algal Diseases

4.10.1. Etiological Agents
4.10.2. Epidemiology
4.10.3. Clinical Manifestations
4.10.4. Specific Diagnosis
4.10.5. Treatment

Module 5. Infectious Diseases in the Feline Species (I). Viral:

5.1. Feline Leukemia Virus (FeLV). Epidemiology and Etiology

5.1.1. Situation in Europe and Latin America
5.1.2. Etiopathogenesis and its Relation to Diagnosis
5.1.3. Clinical Manifestations

5.2. Feline Leukemia Virus. Clinical Manifestations and Treatments

5.2.1. Associated Pathologies
5.2.2. Current Treatments. Evidence and Experience

5.3. Feline Immunodeficiency Virus (FIV)

5.3.1. Etiopathogenesis
5.3.2. Clinical Signs
5.3.3. Diagnosis
5.3.4. Diseases Associated with FIV Infection
5.3.5. Current Treatments

5.4. Feline Coronavirus (FCoV) and Feline Infectious Peritonitis (FIP)

5.4.1. Feline Coronavirus. Epidemiology, Etiopathogenesis and Clinical Signs
5.4.2. Pathogenesis of Feline Infectious Peritonitis (FIP)
5.4.3. Clinical Presentations. Signs and Forms

5.5. Feline Infectious Peritonitis (FIP)

5.5.1. Diagnosis: Combining Clinical and Techniques
5.5.2. Supportive and Experimental Therapies

5.6. Feline Herpesvirus (FHV)

5.6.1. Epidemiology
5.6.2. Pathogenesis and its Relationship to Clinical Signs
5.6.3. Clinical and Laboratory Diagnosis
5.6.4. Supportive and Antiviral Treatments

5.7. Feline Calicivirus (FCV)

5.7.1. Epidemiology
5.7.2. Pathogenesis
5.7.3. Clinical Pictures Associated with FCV and Systemic Virulent Calicivirus (SV-CVF)
5.7.4. Laboratory Diagnosis
5.7.5. Treatment of FCV-Associated Conditions
5.7.6. Supportive Treatment of FCV-VS Infection

5.8. Feline Parvovirus (FPV)

5.8.1. Epidemiology
5.8.2. Etiopathogenesis and its Relationship to Clinical Signs
5.8.3. Laboratory Diagnosis
5.8.4. Supportive Treatment of Feline Panleukopenia

5.9. Rabies in Cats

5.9.1. Epidemiology. Current Situation in Europe and Latin America
5.9.2. Pathogenesis and Clinical Pictures
5.9.3. Laboratory Diagnosis
5.9.4. Treatment and Prevention

5.10. Other Viruses Affecting Cats

5.10.1. Feline Spumavirus
5.10.2. Papillomatosis
5.10.3. Cowpox
5.10.4. Morbillivirus
5.10.5. Pseudorabies
5.10.6. Avian Influenza (H3N2)
5.10.7. SARS-CoV-2

Module 6. Infectious Diseases in the Feline Species (II) Bacteria and Fungi

6.1. Bacteria affecting the Respiratory and Ocular Systems (I)

6.1.1. RespiratoryMycoplasmas 
6.1.2. Chlamydiosis
6.1.3. Bordetella Bronchiseptica

6.2. Bacteria Affecting the Respiratory and Ocular Systems (II)

6.2.1. Pasteurella
6.2.2. Pseudomonas
6.2.3. Klebsiella Pneumoniae
6.2.4. Escherichia coli
6.2.5. Actinomycosis and Nocardiosis

6.3. Bacteria Affecting the Digestive System

6.3.1. Bacteria Affecting the Gastrointestinal Tract

6.3.1.1. Campylobacteriosis
6.3.1.2. Salmonellosis
6.3.1.3. Chlostridiosis
6.3.1.4. Escherichia coli
6.3.1.5. Helicobacter

6.3.2. Bacterial Cholangitis and Bacterial Cholangiohepatitis

6.4. Cutaneous Bacteria

6.4.1. Streptococcus
6.4.2. Staphylococcus
6.4.3. Abscess-Forming Bacteria

6.4.3.1. Nocardiosis
6.4.3.2. Actinomycosis
6.4.3.3. Rhodococcus

6.4.4. Bacteria Involved in Bite Wounds

6.5. Bacteria Affecting the Nervous System

6.5.1. Clostridium Tetani
6.5.2. Clostridium Botulinum
6.5.3. Escherichia coli

6.6. Bacteria Affecting Other Organs. Nephro-urinary Cardiovascular and Systemic System

6.6.1. Gram-Positive Bacteria
6.6.2. Gram-Negative Bacteria
6.6.3. Bartonellosis
6.6.4. Leptospirosis
6.6.5. Management of the Feline Patient with Sepsis

6.7. Hemotropic Mycoplasma

6.7.1. Etiopathogenesis
6.7.2. Epidemiology
6.7.3. Clinical Signs and Diagnosis
6.7.4. Treatment

6.8. Mycobacteriosis

6.8.1. Types of Infections

6.8.1.1. Tuberculosis
6.8.1.2. . Mycobacterium AviumComplex
6.8.1.3. Feline Leprosy

6.8.2. Diagnosis of Mycobacterial Infections
6.8.3. Treatment of Mycobacterial Infections

6.9. Cutaneous Mycoses

6.9.1. Dermatophytosis
6.9.2. . MalasseziaDermatitis

6.10. Systemic and Respiratory Mycoses

6.10.1. Cryptococcosis
6.10.2. Blastomycosis
6.10.3. Aspergillosis and Penicilliosis
6.10.4. Histoplasmosis
6.10.5. Candidiasis
6.10.6. Other Mycosis

Module 7. Infectious Diseases in the Feline Species (III). Parasitic and Vector-Borne Diseases

7.1. Cutaneous Parasites (I)

7.1.1. Epidemiology: Review of the Current Situation in Europe and Latin America
7.1.2. Fleas
7.1.3. Lice
7.1.4. Ticks

7.2. Cutaneous Parasites (II)

7.2.1. Mites

7.2.1.1. Cheyletiella
7.2.1.2. Trombicula
7.2.1.3. Demodectic Mange
7.2.1.4. Otodectic Mange
7.2.1.5. Notohedral Mange
7.2.1.6. Sarcoptic Mange

7.2.2. Helminths

7.2.2.1. Thelazia

7.3. Digestive Parasites (I). Trematodes and Cestodes

7.3.1. Trematodes
7.3.2. Cestodes

7.3.2.1. Dipylidium
7.3.2.2. Tapeworms
7.3.2.3. Echinococcus
7.3.2.4. Mesocestoides

7.4. Digestive Parasites (II). Helminths

7.4.1. Ancylostoma
7.4.2. Uncinaria
7.4.3. Trichostrongylus
7.4.4. Toxocara Cati
7.4.5. Toxocara Canis
7.4.6. Physaloptera

7.5. Digestive Parasites (III). Protozoa

7.5.1. Cryptosporidium
7.5.2. Isospora
7.5.3. Sarcocystis
7.5.4. Tritrichomonas
7.5.5. Giardia
7.5.6. Entamoeba

7.6. Respiratory Parasites

7.6.1. Aleurostrongylus Abstrusus
7.6.2. Oslerus
7.6.3. Toxocara Cati

7.7. Toxoplasmosis

7.7.1. Prevention
7.7.2. Etiopathogenesis
7.7.3. Clinical Signs
7.7.4. Clinical and Laboratory Diagnosis
7.7.5. Treatment

7.8. Vector-Borne Infectious Diseases I

7.8.1. Bartonellosis
7.8.2. Ehrlichiosis
7.8.3. Anaplasmosis
7.8.4. Borreliosis
7.8.5. Coxiellosis

7.9. Vector-Borne Infectious Diseases II

7.9.1. Babesiosis
7.9.2. Cytauxzoonosis
7.9.3. Hepatozoonosis

7.10. Vector-Borne Infectious Diseases III

7.10.1. Leishmaniasis
7.10.2. Dirofilariasis

Module 8. Tropical Diseases

8.1. CanineLeishmaniasis : A View from Latin America

8.1.1. Canine TegumentaryLeishmaniasis in Latin America
8.1.2. Canine VisceralLeishmaniasis in Latin America
8.1.3. Control and Prevention Measures

8.2. Canine Trypanosomiasis

8.2.1. Etiological Agents
8.2.2. Epidemiology
8.2.3. Clinical Manifestations
8.2.4. Specific Diagnosis
8.2.5. Treatment

8.3. Rangeliosis and Other Pyroplasmas

8.3.1. Etiological Agents
8.3.2. Epidemiology
8.3.3. Clinical Manifestations
8.3.4. Specific Diagnosis
8.3.5. Treatment

8.4. Gurltia Paralysans and Lagochilascaris Spp

8.4.1. Etiological Agents
8.4.2. Epidemiology
8.4.3. Clinical Manifestations
8.4.4. Specific Diagnosis
8.4.5. Treatment

8.5. Feline Sporotrichosis

8.5.1. Etiological Agents
8.5.2. Epidemiology
8.5.3. Clinical Manifestations
8.5.4. Specific Diagnosis
8.5.5. Treatment

8.6. Rhinosporidiosis

8.6.1. Etiological Agents
8.6.2. Epidemiology
8.6.3. Clinical Manifestations
8.6.4. Specific Diagnosis
8.6.5. Treatment

8.7. Dioctophimosis

8.7.1. Etiological Agents
8.7.2. Epidemiology
8.7.3. Clinical Manifestations
8.7.4. Specific Diagnosis
8.7.5. Treatment

8.8. Trematodes in Canines and Felines

8.8.1. Etiological Agents
8.8.2. Epidemiology
8.8.3. Clinical Manifestations
8.8.4. Specific Diagnosis
8.8.5. Treatment

8.9. Rabies in the Americas

8.9.1. Background
8.9.2. Epidemiology and Current Situation
8.9.3. Diagnosis, Surveillance and Control

8.10. Leptospirosis in the Americas

8.10.1. Background
8.10.2. Epidemiology and Current Situation
8.10.3. Diagnosis, Surveillance and Control

Module 9. Zoonotic

9.1. Past, Present and Future of Zoonoses

9.1.1. What are Zoonoses?
9.1.2. Types of Zoonoses
9.1.3. Historical Importance
9.1.4. The Role of the Small Animal Veterinarian

9.2. Zoonotic Risk Analysis. Vision One Health

9.2.1. Animal Health Risk Analysis
9.2.2. Risk Analysis Terminology
9.2.3. Stages of the Analysis
9.2.4. Perspectives and Limitations

9.3. Bacterial I. Campylobacteriosis, Salmonellosis and Chlostridiosis

9.3.1. Campylobacteriosis and salmonellosis
9.3.2. Chlostridiosis
9.3.3. Risk Factors
9.3.4. Prevention and Control

9.4. Bacterial II. Brucellosis, Leptospirosis and Bartonellosis

9.4.1. Brucellosis
9.4.2. Leptospirosis
9.4.3. Bartonellosis
9.4.4. Prevention and Control

9.5. Protozoa (I). Giardiasis and Toxoplasmosis

9.5.1. Giardiasis
9.5.2. Toxoplasmosis
9.5.3. Risk Factors
9.5.4. Prevention and Control

9.6. Protozoa (II). Leishmaniasis and Cryptosporidiosis

9.6.1. Leishmaniasis
9.6.2. Cryptosporidiosis
9.6.3. Risk Factors
9.6.4. Prevention and Control

9.7. Nematodes and Cestodes. Toxocara, Dipylidium and Echinococcus

9.7.1. Toxocara
9.7.2. Dipylidium
9.7.3. Echinococcus
9.7.4. Prevention and Control

9.8. Viral. Rabies

9.8.1. Epidemiology
9.8.2. Clinical Picture in Humans
9.8.3. Prophylactic and Control Measures

9.9. Mange and Dermatomycosis

9.9.1. Mange
9.9.2. Dermatomycosis
9.9.3. Prophylaxis and Control

9.10. Antimicrobial Resistance (ARM). Global Risk

9.10.1. Importance of Antimicrobial Resistance
9.10.2. Acquired Mechanisms of Antimicrobial Resistance
9.10.3. Global Strategies for the Reduction of Antimicrobial Resistance

Module 10. Vaccination and prevention

10.1. Vaccination in Dogs I

10.1.1. Types of Vaccines
10.1.2. Canine Vaccination Protocol. Primovaccination and Revaccination
10.1.3. Vaccination Under Special Conditions
10.1.4. Action Protocol
10.1.5. Vaccine Reactions
10.1.6. Immunization Failures. Factors Involved

10.2. Vaccination in Dogs II

10.2.1. Essential Vaccines
10.2.2. Complementary Vaccines
10.2.3. Non-Recommended Vaccines

10.3. Vaccination in Cats I

10.3.1. Feline Vaccination Protocol
10.3.2. Vaccination Under Special Conditions
10.3.3. Action Protocol
10.3.4. Vaccine Reactions. Expected and Undesirable
10.3.5. Immunization Failures. Factors Involved

10.4. Vaccination in Cats II

10.4.1. Essential Vaccines
10.4.2. Complementary Vaccines
10.4.3. Non-Recommended Vaccines

10.5. Preventive Management of Vector-Borne Diseases

10.5.1. Importance of Vector-Borne Disease Management
10.5.2. Factors Involved
10.5.3. Classification of Vector-Borne Diseases According to the Type of Vector Responsible for Vectors

10.6. Preventive Management of External and Internal Parasitosis in Dogs

10.6.1. Importance of Parasitosis Prevention
10.6.2. Factors Involved
10.6.3. Classification of Parasitic Diseases According to the Agent

10.6.3.1. Ectoparasites
10.6.3.2. Endoparasites

10.6.4. Relevance of Combination Therapy

10.7. Preventive Management of External and Internal Parasitosis in the Cat

10.7.1. Importance of Parasitosis Prevention
10.7.2. Factors Involved
10.7.3. Classification of Parasitic Diseases According to the Agent

10.7.3.1. Ectoparasites
10.7.3.2. Endoparasites

10.7.4. Relevance of Combination Therapy

10.8. Sanitary Management of Kennels

10.8.1. Characteristics of the Facilities
10.8.2. Cleaning. Order and Products to be Used
10.8.3. Vaccination Programs
10.8.4. Deworming Programs
10.8.5. Sanitary Vacuum. Why, When and How to Perform it

10.9. Sanitary Management of Catteries

10.9.1. Characteristics of the Facilities
10.9.2. Cleaning. Order and Products to be Used
10.9.3. Vaccination Programs
10.9.4. Deworming Programs
10.9.5. Sanitary Vacuum. Why, When and How to Perform it

10.10. Disaster Management

10.10.1. Main Types of Disasters

10.10.1.1. Meteorological Disasters
10.10.1.2. Natural Disasters
10.10.1.3. Biological Disasters Pandemics

10.10.2. Preventive Measures

10.10.2.1. Census of Animals
10.10.2.2. Preparation and Organization of Facilities to be Used as Shelter
10.10.2.3. Personnel and Means of Transport
10.10.2.4. Current Legislation in Force in Cases of Catastrophes in Relation to Companion Animals 

Thanks to the 100% online methodology in which the theoretical phase of this Hybrid Master's Degree is taught, you will achieve optimized learning at any time and place”